Qube Research & Technologies LTD Merck & Co., Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 4,022,464 shares of MRK stock, worth $346 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
4,022,464
Previous 3,433,412
17.16%
Holding current value
$346 Million
Previous $308 Million
3.32%
% of portfolio
0.34%
Previous 0.37%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,842Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.2 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.61 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.07 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $218B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...